<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2024.1391824</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Pathoimmunological analyses of fatal E11 infection in premature infants</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Luo</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2639793"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Lixia</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Zhengrong</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Ming</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Yixue</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Yucan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huang</surname>
<given-names>Bing</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Ping</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2038802"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Neonatology, Guangzhou Women and Children&#x2019;s Medical Center, Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>College of Pediatrics, Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hospital, Southern Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ming Yue, Nanjing Medical University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Shubhada Bopegamage, Slovak Medical University, Slovakia</p>
<p>Haider Al-Hello, Finnish Institute for Health and Welfare, Finland</p>
<p>Zhenhua Zheng, Chinese Academy of Sciences (CAS), China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Ping Wang, <email xlink:href="mailto:wangping486@126.com">wangping486@126.com</email>; Bing Huang, <email xlink:href="mailto:huangb1ng@smu.edu.cn">huangb1ng@smu.edu.cn</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>07</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>14</volume>
<elocation-id>1391824</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>06</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Luo, Wang, Chen, Liu, Zhao, Wu, Huang and Wang</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Luo, Wang, Chen, Liu, Zhao, Wu, Huang and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>E11 causes acute fulminant hepatitis in newborns. We investigated the pathological changes of different tissues from premature male twins who died due to E11 infection. The E11 expression level was higher in the liver than in other tissues. IP10 was upregulated in liver tissue in the patient group, and might be regulated by IFNAR and IRF7, whereas IFN&#x3b1; was regulated by IFNAR or IRF5.</p>
</abstract>
<kwd-group>
<kwd>acute fulminant hepatitis</kwd>
<kwd>E11</kwd>
<kwd>IFN&#x3b1;</kwd>
<kwd>IP10</kwd>
<kwd>premature male twins</kwd>
</kwd-group>
<contract-num rid="cn001">2022A1515012354</contract-num>
<contract-sponsor id="cn001">Basic and Applied Basic Research Foundation of Guangdong Province<named-content content-type="fundref-id">10.13039/501100021171</named-content>
</contract-sponsor>
<counts>
<fig-count count="3"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="35"/>
<page-count count="9"/>
<word-count count="4658"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Virus and Host</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Echovirus type 11 (E11) is the most prevalent subtype belonging to the family Picornaviridae, genus Enterovirus. In most cases, echovirus infections follow a benign, self-limiting course, manifesting either asymptomatically or with fever. However, the impact on newborns, particularly premature infants, can often lead to severe complications such as myocarditis, liver failure, coagulation disorders with reduced platelets, and even death (<xref ref-type="bibr" rid="B7">Chuang and Huang, 2019</xref>; <xref ref-type="bibr" rid="B35">Zhang et&#xa0;al., 2021</xref>). In recent years, sporadic outbreaks of E11 infection have been reported in Europe (<xref ref-type="bibr" rid="B12">Grapin et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B24">Piralla et&#xa0;al., 2023</xref>), and prior to the prevalence of the coronavirus disease 2019, Asia also witnessed widespread outbreaks (<xref ref-type="bibr" rid="B22">Patel et&#xa0;al., 1985</xref>; <xref ref-type="bibr" rid="B14">Ho et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B6">Chen et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B30">Wang et&#xa0;al., 2023b</xref>). Reports of serious consequences in premature infants due to this virus have been on the rise. According to World Health Organization data, the proportion of severe infections in newborns has increased from 6.2% in 2016 to 55% in 2022. Clinical manifestations may include coagulation disorders and liver damage, with critically ill patients developing acute fulminant liver failure. However, the reasons for the severe liver damage caused by E11 in premature infants remain unclear, primarily due to the lack of comparative clinical histopathology.</p>
<p>This study described findings on a pair of premature male twins who suffered from liver damage and succumbed to E11 infection. It offered a comprehensive analysis of the pathological and immunological characteristic differences in liver tissues between infants with E11 infection and control group. By combining clinical biochemical indicators, histopathology, and cytokine immunology, we elucidated the abnormal expression of interferon &#x3b1; (IFN&#x3b1;) and interferon-inducible protein-10 (IP10) in severe cases of E11 infection and discussed potential molecular mechanisms. The aim was to offer new insights into the early diagnosis and treatment of severe liver damage caused by E11 infection in premature infants.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Study participants</title>
<p>The cases documented in this study involved a pair of premature male twins admitted to the Neonatal Intensive Care Unit (NICU) of Guangzhou Women and Children&#x2019;s Medical Center during the 2019 E11 outbreak in China. Throat and rectal swabs were collected for E11 detection using polymerase chain reaction amplification and sequencing methods, confirming the presence of E11 infection. Both infants began exhibiting symptoms on the 7th day of life, with patient 1 succumbing on the 20th day and patient 2 on the 26th day after birth.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Control participants</title>
<p>The liver tissue samples from the control group were obtained from three children with normal liver function who required surgery for choledochal cysts. The lung tissue samples were from a 5-month-old male patient undergoing right upper lobe anterior segmentectomy due to congenital pulmonary malformation (type 2). The specimen was extracted from the surrounding normal lung tissue of the lesion.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Histopathological analysis</title>
<p>Liver, lung, and intestinal tissue samples were obtained through needle aspiration. The liver, lung, and intestinal tissues of control participants were collected during surgery. All tissue samples were fixed with 4% paraformaldehyde, embedded in paraffin, and then sectioned (2&#x2013;4 mm thickness). Morphological evaluation was performed using hematoxylin and eosin (H&amp;E) staining.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Immunofluorescence staining</title>
<p>Paraffin-embedded sections were deparaffinized and incubated in a blocking buffer (PBS with 5% normal goat serum and 0.3% Triton X-100) for 1 hour. Next anti-human IP-10 (Cat# ab9807; Abcam, Cambridge, UK), was added and incubation continued overnight in a wet chamber at 4&#xb0;C in the dark. Sections were then washed with PBS, incubated with secondary antibodies for 1 hour at room temperature in the dark, and mounted with VECTASHIELD Antifade Mounting Medium with DAPI (H-1200, Vector Laboratories) for nuclear staining. Immunofluorescent images were acquired with a Leica TCS SP8 Inverted Fluorescence Microscope (Leica Microsystems, Buffalo Grove, IL, USA) using a 10&#xd7;0.32 dry objective lens and analyzed with Leica X image analysis software.</p>
<p>Paraffin-embedded sections were deparaffinized and incubated in a blocking buffer (PBS with 5% normal goat serum and 0.3% Triton X-100) for 1 hour. They were then stained with Anti-Echovirus Blend Antibody (MAB9670; Sigma) overnight in a wet chamber at 4&#xb0;C in the dark. Sections were then washed with PBS, incubated with Goat Anti-Mouse IgG-Alexa Fluor 488 (ab150117; Abcam) (1:200) for 1.5 hour at room temperature in the dark, and mounted with VECTASHIELD Antifade Mounting Medium with DAPI (H-1200; Vector Laboratories) for nuclear staining. Immunofluorescent images were acquired using a Leica TCS SP8 Inverted Fluorescence Microscope (Leica Microsystems) using a 20&#xd7;0.75 dry objective lens. Post-acquisition processing (brightness, opacity, contrast, and color balance) was applied uniformly to all images to accurately reflect the original results. For each section, five areas were selected from 200&#xd7; magnified images for quantification. The number of Echovirus (&gt; 3 &#x3bc;m in diameter) per square millimeter was counted and analyzed using Leica X image analysis software (Leica, Hamburg, Germany) and ImageJ software (National Institutes of Health, MD, USA).</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Multiplexed immunohistochemistry</title>
<p>Multiplexed immunohistochemistry was performed by staining 4-&#xb5;m-thick formalin-fixed, paraffin-embedded whole tissue sections with standard, primary antibodies sequentially and paired with tyramide signal amplification (TSA) seven-color kit (abs50015-100T; Absinbio;China). Afterward, deparaffinized slides underwent DAPI staining. Specifically, these slides were incubated with anti-IP10 antibody (#bs-1502R; Bioss; China) for 30&#xa0;min and then treated with anti-rabbit/mouse horseradish peroxidase (HRP)&#x2013;conjugated secondary antibody (#ARH1001EA; Absinbio; China) for 10&#xa0;min. Labeling was then performed for 10&#xa0;min using TSA 520, following the manufacturer&#x2019;s protocols. The slides were then washed with TBST and transferred to a preheated citrate solution (90&#xb0;C). Subsequently, they underwent heat treatment in a microwave set to 20% of its maximum power for 15&#xa0;min. The slides were then cooled in the same solution to room temperature and washed with Tris buffer between steps. The same process was repeated for the following antibodies/fluorescent dyes, in the order of anti-IFNa (#NBP2-75930; Novus; USA), anti-IRF7 (#sc-74472; Santa Cruz;USA), anti-IRF5 (#orb192097; Biorbyt;UK), anti-IRF3 (#11904; CST; USA), anti-IFNRA (#orb673775; Biorbyt; UK), and anti-CD68 (#ab955; Abcam; UK). Subsequently, each slide was treated with two drops of DAPI (FP1490; Thermo Fisher Scientific; USA), washed with distilled water, and manually cover slipped. Following this, the slides were air-dried, and pictures were taken using the Aperio Versa 8 tissue imaging system. The images were analyzed using Indica HALO software.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Statistical analysis</title>
<p>Prism 9.0 (GraphPad) software was used for statistical analysis and cartography. The unpaired <italic>t</italic> test was performed to analyze of two groups. Simple linear regression was used to analyze the correlation between the expression of different cytokines. Statistical significance was defined as P &lt; 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Cases and laboratory investigations</title>
<p>The twins included in this study were born in June 2019. Both infants exhibited gastrointestinal symptoms 7 days after birth, and their conditions rapidly deteriorated within 1 day. The twins were transferred from an external neonatal department to the NICU at Guangzhou Women and Children&#x2019;s Medical Center on day 9 of life because of the severity of their illness. They were diagnosed with E11 infection on the 11th day. The twins were also tested for coxsackievirus, Epstein-Barr virus, herpes simplex virus, cytomegalovirus, human parvovirus, and adenovirus after admission, all of which were negative.</p>
<sec id="s3_1_1">
<label>3.1.1</label>
<title>Birth history</title>
<p>The twins were conceived through <italic>in vitro</italic> fertilization, specifically as monochorionic diamniotic. Their gestation age were 32 + <sup>5</sup> weeks. The firstborn (P1) experienced premature rupture of membranes for 25 hours, with clear amniotic fluid and umbilical cord wrapped around the neck once. No complications were observed during delivery, and both infants were admitted to the local neonatal department due to prematurity and low birth weight. P1 and P2 had birth weights of 1.65&#xa0;kg (22nd percentile) and 1.8&#xa0;kg (34th percentile), respectively. The mother had regular prenatal check-ups, with no symptoms of vomiting, diarrhea, or fever during pregnancy. No instances of gestational diabetes or gestational hypertension were observed. Apart from the administration of dexamethasone for fetal lung maturation, no other medications were administered before delivery.</p>
</sec>
<sec id="s3_1_2">
<label>3.1.2</label>
<title>Clinical course of P1</title>
<p>P1 started vomiting frequently on the 7th day after birth and developed uncorrectable hypotension, oliguria, generalized edema, skin ecchymosis (particularly in the limbs), and hypoxemia by the 8th day. The laboratory results revealed metabolic acidosis, significant coagulation abnormalities, and abnormal liver function. On the 9th day after birth, P1 was transferred to the NICU at Guangzhou Women and Children&#x2019;s Medical Center. On admission, P1 exhibited poor responsiveness, irregular breathing, pronounced edema, anuria, and laboratory findings revealed respiratory and metabolic acidosis, severe anemia, thrombocytopenia, coagulation disorders, and abnormal liver function. Despite interventions, including mechanical ventilation, antimicrobial therapy, blood product transfusions, and various vasopressors, P1&#x2019;s condition continued to deteriorate. Continuous renal replacement therapy(CRRT) was initiated on the 11th day, with plasma exchange performed on the 17th and 19th days. Complications, such as pulmonary arterial hypertension, occurred, and the family chose to discontinue treatment on the 20th day due to multi-organ bleeding.</p>
</sec>
<sec id="s3_1_3">
<label>3.1.3</label>
<title>Clinical course of P2</title>
<p>P2 also experienced apnea on the 7th day after birth, accompanied by a decrease in oxygen saturation. On the same day, P2 began vomiting coffee-ground-vomited. On the 8th day, P2 exhibited the same symptoms as P1, and was also transferred to the same hospital. Upon admission, P2 displayed poor responsiveness, irregular breathing, significant edema, oliguria, and laboratory findings revealed with respiratory and metabolic acidosis, severe anemia, thrombocytopenia, coagulation disorders, and liver dysfunction. Like P1, P2 underwent various treatments, including respiratory support, inhaled nitric oxide, antimicrobial agents, immunoglobulin, blood product transfusions, vasopressors, and fluid resuscitation. CRRT was initiated on the 13th day, with four rounds of plasma exchange performed. Despite active treatment, P2&#x2019;s clinical symptoms persisted, accompanied by multi-organ damage, severe acidosis, hypotension, and hypoxemia. Unfortunately, resuscitation efforts were unsuccessful, and P2 succumbed on the 26th day after birth.</p>
<p>The male premature twins infected with E11 exhibited a swift disease progression and severe symptoms. Gastrointestinal symptoms such as vomiting were the first symptoms, and the disease rapidly developed into multiple organ failure within a day, with particularly severe liver damage. This was evident in the form of fulminant hepatic failure characterized by a rapid increase in liver enzymes and bilirubin levels, along with abnormalities in coagulation factors (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Laboratory result about a pair of premature male twins with E11 infection.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Laboratory findings</th>
<th valign="top" align="center">P1</th>
<th valign="top" align="center">P2</th>
<th valign="top" align="center">Reference range</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">Minimum platelet value (10^9/L)</td>
<td valign="top" align="center">9.0</td>
<td valign="top" align="center">7.0</td>
<td valign="top" align="center">140-440</td>
</tr>
<tr>
<td valign="middle" align="center">Minimum hemoglobin value  (g/L)</td>
<td valign="top" align="center">46.0</td>
<td valign="top" align="center">60.0</td>
<td valign="top" align="center">135-195</td>
</tr>
<tr>
<td valign="middle" align="center">ALT peak (U/L)</td>
<td valign="top" align="center">228.0</td>
<td valign="top" align="center">285.0</td>
<td valign="top" align="center">9-50</td>
</tr>
<tr>
<td valign="middle" align="center">AST peak (U/L)</td>
<td valign="top" align="center">3055.0</td>
<td valign="top" align="center">3255.0</td>
<td valign="top" align="center">5-60</td>
</tr>
<tr>
<td valign="middle" align="center">TBIL peak  (umol/L)</td>
<td valign="top" align="center">274.0</td>
<td valign="top" align="center">686.7</td>
<td valign="top" align="center">2-17</td>
</tr>
<tr>
<td valign="middle" align="center">DBIL peak  (umol/L)</td>
<td valign="top" align="center">36.3</td>
<td valign="top" align="center">132.0</td>
<td valign="top" align="center">2-13.7</td>
</tr>
<tr>
<td valign="middle" align="center">&#x3b3;-GT peak (U/L)</td>
<td valign="top" align="center">206.0</td>
<td valign="top" align="center">145.0</td>
<td valign="top" align="center">10-60</td>
</tr>
<tr>
<td valign="middle" align="center">Minimum albumin  (g/L)</td>
<td valign="top" align="center">20.8</td>
<td valign="top" align="center">24.8</td>
<td valign="top" align="center">40-50</td>
</tr>
<tr>
<td valign="middle" align="center">APTT (s),mean (min,max)</td>
<td valign="top" align="center">112.5 (46.8-180.0)</td>
<td valign="top" align="center">91.8 (48.1-180,0)</td>
<td valign="top" align="center">28-45</td>
</tr>
<tr>
<td valign="middle" align="center">PT (s),mean (min,max)</td>
<td valign="top" align="center">26.0 (14.2-120.0)</td>
<td valign="top" align="center">27.8 (15.3-98.1)</td>
<td valign="top" align="center">11-15</td>
</tr>
<tr>
<td valign="middle" align="center">TT (s),mean (min,max)</td>
<td valign="top" align="center">98.5 (19.5-240.0)</td>
<td valign="top" align="center">78.9 (21.3-240.0)</td>
<td valign="top" align="center">14-21</td>
</tr>
<tr>
<td valign="middle" align="center">FIB (g/L),mean (min,max)</td>
<td valign="top" align="center">2.2 (0.6-3.4)</td>
<td valign="top" align="center">2.1 (0.6-5.2)</td>
<td valign="top" align="center">2-4g/L</td>
</tr>
<tr>
<td valign="middle" align="center">IL6 (pg/ml),mean (min,max)</td>
<td valign="top" align="center">113519.5 (4760.0-162890.2)</td>
<td valign="top" align="center">19921.3 (1760.66-53500.4)</td>
<td valign="top" align="center">0-8.88</td>
</tr>
<tr>
<td valign="middle" align="center">IL8 (pg/ml),mean (min,max)</td>
<td valign="top" align="center">112353.4 (3074.3-1703.0)</td>
<td valign="top" align="center">58304.3 (1313.67-170306.6)</td>
<td valign="top" align="center">0-15.71</td>
</tr>
<tr>
<td valign="middle" align="center">IL10 (pg/ml),mean (min,max)</td>
<td valign="top" align="center">381.6 (28.1-609.0)</td>
<td valign="top" align="center">308.1 (5.65-1303.7)</td>
<td valign="top" align="center">0-8.14</td>
</tr>
<tr>
<td valign="middle" align="center">IFN&#x3b1; (pg/ml),mean (min,max)</td>
<td valign="top" align="center">450.0 (328.5-775.1)</td>
<td valign="top" align="center">201.1 (44.4-656.8)</td>
<td valign="top" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="center">IP10 (pg/ml),mean (min,max)</td>
<td valign="top" align="center">126512.0 (62617.2-135872.7)</td>
<td valign="top" align="center">89320.7 (62224.6-120162.1)</td>
<td valign="top" align="center">&#x2013;</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Histopathological analysis of the liver, intestine, and lungs</title>
<p>In the liver tissue of the twins, the hepatic lobular structure was not clearly visible under H&amp;E staining. Multifocal patchy necrosis of hepatocytes, fragmentation, and dissolution of hepatocyte nuclei were observed. This was accompanied by a significant infiltration of inflammatory cells, primarily lymphocytes, and marked expansion of the portal areas. In contrast, the liver tissue from the control group exhibited a clear hepatic lobular structure at low magnification. The hepatocytes did not show degeneration or accumulation, and the portal areas were slightly enlarged but structurally intact, with minimal lymphocyte infiltration. Compared with the control, the intestinal villi were absent and the intestinal epithelial cells were reduced and disorganized in the twins. The microscopic examination of lung tissue from the control group revealed intact structures of small bronchi and alveoli. In contrast, the deceased twins exhibited inflammatory cell infiltration in the interstitium of the lungs, accompanied by pulmonary emphysema (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Pathological examination of multiple organ tissues between the deceased twins and the control group. (HE stain; 20&#xd7;10). The column on the right is &#xd7;4 magnified on the left. Liver sections of twins showed that multifocal patchy necrosis of hepatocytes, fragmentation, and dissolution of hepatocyte nuclei(arrow), accompanied by a significant infiltration of inflammatory cells, primarily lymphocytes, and marked expansion of the portal areas. The liver cells of control group did not show degeneration or accumulation(arrow), and the portal areas were slightly enlarged but structurally intact, with minimal lymphocyte infiltration. Intestine sections of twins showed the intestinal villi were absent and the intestinal epithelial cells were reduced and disorganized (arrow). The control group revealed dense villi in the mucosal layer of the small intestine, well-arranged and tightly packed intestinal epithelial cells with a clear brush border (arrow), and clusters of lymphocytes in the lamina propria. Lung sections of twins exhibited inflammatory cell infiltration in the interstitium of the lungs, accompanied by pulmonary emphysema(arrow). Lung sections of the control showed the structure of bronchioles and alveoli is intact.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1391824-g001.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Expression of E11 and IP10 in different tissues</title>
<p>To further investigate the distribution of E11 in different tissues and organs, we used immunofluorescence staining to compare the expression and distribution of E11 in the lungs, intestines, and liver of twins. The results showed that E11 was expressed in the lungs, intestines, and liver, with the highest number of virus positive cells in the liver. In addition, E11 exhibited focal aggregation in intestinal epithelial cells rather than a diffuse distribution. IP10 expression to be expressed in different tissues in the intestine, lungs, and liver, with the highest expression observed in the intestine, followed by the liver, and rarely expressed in the lungs. In summary, E11 mainly localized to the liver, followed by the intestine and lungs, and its distribution might correlated positively with IP10 expression (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>
<bold>(A-C)</bold> show the expression and distribution of representative immunofluorescence of E11 in the intestine, lungs, and liver of the deceased twins and control group. Green represents E11, and blue represents the nucleus. White arrows indicate E11. <bold>(D)</bold> displayed statistical analysis based on immunofluorescence in <bold>(A-C, E)</bold> show the expression and distribution of IP10 in the different tissues. Red represents IP10, and blue represents the nucleus. White arrows indicate IP10. <bold>(F)</bold> displayed statistical analysis based on the observed immunofluorescence in <bold>(E)</bold>. N.S, no significace, * P value &lt;0.05, ** P value &lt;0.01, *** P value &lt;0.001 and **** P value &lt;0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1391824-g002.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Expression of IFN&#x3b1; upstream factors in liver tissue</title>
<p>Our previous studies reported decreased peripheral-blood levels of IFN&#x3b1; in infants with severe liver damage compared with those with mild symptoms without liver dysfunction (<xref ref-type="bibr" rid="B30">Wang et&#xa0;al., 2023b</xref>). We conducted multicolor immunofluorescence staining to analyze the expression of IFN&#x3b1;, interferon &#x3b1; receptor(IFNAR), IP10, IRF3, IRF5, and IRF7 in the liver tissue of the twins and compared it with that in the control group. We selected IFN&#x3b1;, IFNAR, and IP10 as Panel 1, and IRF3, IRF5, and IRF7 as Panel 2.</p>
<p>The results showed that both hepatocytes and Kupffer cells exhibited a significant increase in IP10 expression in severe cases, consistent with our peripheral blood serum results. However, elevated IFN&#x3b1; levels were observed only in Kupffer cells, not in hepatocytes (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). Additionally, IFNAR expression was higher in Kupffer cells of severe cases compared with the control group, whereas no statistical difference was observed in hepatocytes (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). We found that the levels of IRF3, IRF5, and IRF7 in Kupffer cells were higher in severe cases compared with the control group. However, IRF5 expression in hepatocytes decreased in severe cases (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>
<bold>(A)</bold> show the expression and distribution of representative multicolored immunofluorescence of IFN&#x3b1;, IFNRA, IP10, IRF3, IRF5, and IRF7 in liver tissue of the deceased twin and control groups. IFN&#x3b1;, IFNAR, and IP10 as Panel 1(green represents IP10, yellow represents IFN&#x3b1;, orange represents IFNRA, pink represents CD68, and blue represents the nucleus), and IRF3, IRF5, and IRF7 as Panel 2(green represents IRF7, yellow represents IRF5, orange represents IRF3, pink represents CD68 and blue represents the nucleus). <bold>(B)</bold> displayed statistical analysis based on <bold>(A)</bold>. <bold>(C)</bold> displayed IP10 and IFN&#x3b1; correlation with IRF7, IRF5, IRF3, and IFNAR, respectively. N.S, no significace, * P value &lt;0.05, ** P value &lt;0.01, *** P value &lt;0.001 and **** P value &lt;0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1391824-g003.tif"/>
</fig>
<p>We performed multicolor immunofluorescence-based correlation analysis between IP10, IFN&#x3b1;, and the transcription factors IRF3, IRF5, and IRF7 to identify the transcription factors regulating IP10 and IFN&#x3b1;. The results indicated no significant correlation between these inflammatory factors and IRF3, IRF5, or IRF7 at the total cellular level (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). However, in liver Kupffer cells, a weak positive correlation was observed between IRF7 and both IP10 and IFN&#x3b1;. In contrast, in non-Kupffer cells within the liver, only IRF7 showed a significant positive correlation with IP10 (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Notably, in liver Kupffer cells, both IP10 and IFN&#x3b1; exhibited a significant positive correlation with IFNAR. In summary, the results suggested that IP10 from liver Kupffer cells might be regulated by both IFNAR and IRF7, whereas IFN&#x3b1; was primarily regulated by IFNAR or IRF5.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>E11 is notably associated with sepsis and acute fulminant hepatitis in newborns, often leading to neonatal deaths (<xref ref-type="bibr" rid="B4">Bubba et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B35">Zhang et&#xa0;al., 2021</xref>). Severe cases have received increased attention from researchers. Reports from different countries in recent years have documented cases of severe liver failure and even death in newborns infected with E11 (<xref ref-type="bibr" rid="B12">Grapin et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B24">Piralla et&#xa0;al., 2023</xref>), with premature birth and male sex identified as potential susceptibility factors, but the specific pathogenic mechanisms remain unclear. One study reported nine cases, with eight being male premature twins (<xref ref-type="bibr" rid="B12">Grapin et&#xa0;al., 2023</xref>). The cases presented in this study also concern male premature twins infected around the age of 1 week, rapidly progressing to acute fulminant hepatitis, similar to cases reported in Italy and France (<xref ref-type="bibr" rid="B12">Grapin et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B24">Piralla et&#xa0;al., 2023</xref>). Based on clinical manifestations, this study delved deeper into the pathogenesis from the perspectives of histopathology and cytokine immunology.</p>
<p>This study was novel in comparing the histopathological changes in different tissues following E11 infection with normal controls. Viral quantification studies were also conducted on various tissue samples from patients. Unlike other enteroviruses such as <italic>Enterovirus A71</italic> (EV71) (<xref ref-type="bibr" rid="B15">Huang et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B20">Moshiri et&#xa0;al., 2023</xref>) and <italic>Coxsackievirus B3</italic> (CVB3) (<xref ref-type="bibr" rid="B18">Massilamany et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B11">Garmaroudi et&#xa0;al., 2015</xref>), severe E11 infection prominently manifests as notable liver damage. The histopathological findings from liver autopsy samples of the twins were consistent with the pathological changes of liver failure. Immunofluorescence staining revealed a significantly higher number of virus-positive cells in the liver compared with the intestine and lungs. This confirmed, for the first time in human samples, that the liver was a crucial target organ for E11-induced sepsis. A previous study by Wells et&#xa0;al. reported a similar phenomenon in mouse model of echovirus infection (<xref ref-type="bibr" rid="B31">Wells et&#xa0;al., 2022</xref>), but severe E11 infection occurred only when the IFNAR gene was knocked out. However, in this study, a comparison of IFNAR expression in liver tissue between the case and control groups revealed that the expression in Kupffer cells of the case group was significantly higher than that in the control group, with no statistical difference in hepatocytes. This result suggested that, although the key point leading to severe infection in animal experiments was the knockout of IFNAR, the key regulatory mechanism in severe cases might be associated with abnormalities in other key points of the IFN&#x3b1; signaling pathway.</p>
<p>IFN&#x3b1; originating from extraepithelial sources is crucial for constraining enterovirus replication in the human intestine and is secreted by most types of cells (<xref ref-type="bibr" rid="B28">Vilcek and Oliveira, 1994</xref>). They can initiate signal transduction through autocrine or paracrine mechanisms, forming ternary receptor complexes with their respective receptors to induce IFN-mediated immune responses (<xref ref-type="bibr" rid="B27">Schneider et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B26">Saxena et&#xa0;al., 2017</xref>).Our team previously validated significantly lower levels of IFN&#x3b1; in the peripheral-blood serum of patients with severe liver injury infected with E11 compared with mild cases (<xref ref-type="bibr" rid="B30">Wang et&#xa0;al., 2023b</xref>). Animal experiments have demonstrated that, without knocking out the IFNAR gene, E11 infection remains localized to the intestine. However, after the gene is knocked out, blocking the normal function of IFN&#x3b1; allows E11 infection to spread systemically (<xref ref-type="bibr" rid="B31">Wells et&#xa0;al., 2022</xref>). The decreased levels of IFN&#x3b1; in patients with severe liver injury infected with E11 might contribute to the virus spreading and causing liver failure in severe cases. The expression of upstream transcription factors of IFN&#x3b1; in the liver tissue of these twins was examined to further explore the specific regulatory mechanisms. The expression level of IRF5 in the liver tissue was observed to be significantly lower than that in the control group. A weak positive correlation between IFN&#x3b1; and IRF5 was observed in Kupffer cells within the liver. Numerous studies have demonstrated that IRF3, IRF5, and IRF7 are involved in the activation and secretion of Type-I IFNs after viral invasion, playing a synergistic role in this process (<xref ref-type="bibr" rid="B1">Barnes et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B2">Barnes et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B23">Paun et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B16">Jefferies, 2019</xref>; <xref ref-type="bibr" rid="B21">Nie et&#xa0;al., 2019</xref>). Upon activation of Toll-like receptors (TLRs) 7, 8, or 9 by exogenous nucleic acids, a supramolecular organizing center is formed, connecting endosomal TLRs with enzymes and ubiquitin-modified proteins. The formation of this complex in the early endosome leads to the activation of NF-&#x3ba;B and the transcription of pro-inflammatory cytokines. Simultaneously, IRF5 is recruited to lysosomes and undergoes phosphorylation. Subsequently, IRF5 translocates to the cell nucleus, initiating the transcription of Type-I IFN genes (<xref ref-type="bibr" rid="B10">Elkon and Briggs, 2020</xref>). IRF5 may directly impact the secretion of IFN&#x3b1; and also influence the synergistic action among various regulatory factors, affecting the body&#x2019;s antiviral capabilities. Therefore, IRF5 may be one of the therapeutic targets for treating acute fulminant liver failure caused by E11 in newborns. Additionally, studies have reported that viral proteins selectively act on a specific target within the IFN signaling pathway, causing damage to the IFN signal transduction pathway (<xref ref-type="bibr" rid="B25">Rasti et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B17">Ji et&#xa0;al., 2023</xref>). Further studies are needed to confirm whether the downregulation of IRF5&#xa0;expression in severe E11 infection is due to a specific viral component.</p>
<p>IFN&#x3b1; and IP10 are two key factors that modulate the immune reaction of type 1 T helper cells (Th1 cells). IP10, a member of the CXC chemokine subfamily, acts as a chemoattractant for activated T cells (<xref ref-type="bibr" rid="B5">Chen et&#xa0;al., 2013</xref>). It increases the migration of Th1 cells. IFN&#x3b1; prompts the proliferation of cytotoxic CD8<sup>+</sup> T cells and the release of IFN&#x3b3; (<xref ref-type="bibr" rid="B13">Hervas-Stubbs et&#xa0;al., 2010</xref>). The dysfunction of excreting IFN&#x3b1; in premature infants cannot stimulate the anti-E11 reaction. More IP10 was produced to recruit additional lymphocytes as feedback to the low level of IFN&#x3b1; (<xref ref-type="bibr" rid="B3">Brownell and Polyak, 2013</xref>; <xref ref-type="bibr" rid="B8">Dai et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B33">Yu et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B34">Zhang et&#xa0;al., 2022</xref>). The elevated expression of IP10 in the liver of the twins in this study aligned with previous findings associating IP10 levels with hepatic injury. <italic>In vitro</italic> experiments have demonstrated that E11 can induce IP10 expression (<xref ref-type="bibr" rid="B9">Drummond et&#xa0;al., 2017</xref>), a phenomenon not observed with other enteroviruses such as EV71 and CVB3. The elevated expression of IP10 appears to be a characteristic feature of E11 among enteroviruses. Animal studies have further confirmed that E11 induces the secretion and aggregation of IP10 in the liver, leading to severe hepatic damage (<xref ref-type="bibr" rid="B32">Wells et&#xa0;al., 2021</xref>). Following invasion of liver cells, E11 triggers significant IP10 secretion, attracting macrophages and natural killer cells to the liver. This leads to acute inflammatory responses and cytotoxic immune reactions, ultimately resulting in extensive hepatocyte necrosis. Therefore, inhibiting IP10 may serve as one of the therapeutic targets for treating E11-induced liver injury. Animal experiments have revealed that, during sepsis, myeloid-related protein 8/14 (MRP8/14) induces sustained IP10 production through the IFN-&#x3b2;-JAK1/TYK2-STAT1-IRF7 pathway (<xref ref-type="bibr" rid="B29">Wang et&#xa0;al., 2023a</xref>). Our findings were consistent with the results of these animal experiments, suggesting that IRF7 might also be one of the targets implicated in severe E11 infection leading to liver injury.</p>
<p>E11, similar to other enteroviruses, primarily spreads through the fecal&#x2013;oral route, using the gastrointestinal tract as its main entry point (<xref ref-type="bibr" rid="B19">Morosky et&#xa0;al., 2019</xref>). Virus-positive cells were detected in the intestinal epithelium of the twins examined in this study, exhibiting a focal rather than diffuse distribution. This pattern might be linked to the involvement of various cell types in the viral invasion of the intestinal epithelium. Previous studies have indicated E11 replication in intestinal epithelial cells and enteroendocrine cells, but not in goblet cells (<xref ref-type="bibr" rid="B9">Drummond et&#xa0;al., 2017</xref>). Our observations also revealed intestinal damage in severe cases, characterized by the disappearance of intestinal villi structure and the presence of reduced and disorganized intestinal epithelial cells. This finding contrasted with the results of animal experiments where virus replication was confined to intestinal epithelial cells, and no damage to the intestinal epithelium was observed (<xref ref-type="bibr" rid="B31">Wells et&#xa0;al., 2022</xref>).</p>
<p>This study was the initial investigation into immunological characteristics using patient tissue samples, validating findings from animal experiments and proposing potential mechanisms for developing severe illness. However, its limitations included the absence of liver tissue samples from patients with mild E11 infection for comparative analysis, as the control cases involved non-E11-infected individuals. Additionally, this study provided only a preliminary exploration of upstream factors affecting IFN&#x3b1; and IP10, necessitating further clinical data and animal experiments to reveal the regulatory roles of IRF5, IRF7, and IFNAR in severe E11 infection in neonates.</p>
<p>In summary, this study was novel in exploring severe E11 infection in premature male twins at the tissue level. The findings, coupled with multicolor immunofluorescence, might offer initial insights into the potential mechanisms and prospective targets for preventing and treating severe preterm E11 infection.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by the Institutional Review Board of Guangzhou Women and Children&#x2019;s Medical Centre (GWCMC-(2020)63201). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants&#x2019; legal guardians/next of kin.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>WL: Data curation, Investigation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. LW: Formal analysis, Investigation, Software, Writing &#x2013; original draft. ZC: Project administration, Writing &#x2013; review &amp; editing. ML: Methodology, Writing &#x2013; review &amp; editing. YZ: Investigation, Writing &#x2013; review &amp; editing. YW: Investigation, Writing &#x2013; review &amp; editing. BH: Data curation, Investigation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Formal analysis, Project administration, Software. PW: Data curation, Investigation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Methodology, Supervision.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Basic and Applied Basic Research Foundation of Guangdong Province (No. 2022A1515012354 to PW), the Plan on Enhancing Scientific Research in Guangzhou Medical University (No. 02-410-2302158XM to PW), and the Basic Research Program of Guangzhou (No.2024A03J1168 to PW). </p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2024.1391824/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2024.1391824/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.jpeg" id="SM1" mimetype="image/jpeg">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p><bold>(A)</bold> is the Panel 1. It shows the expression and distribution of IP10, IFN&#x03b1;, and IFNRA in liver tissues of the deceased twins and control group, respectively (green represents IP10, yellow represents IFN&#x03b1;, orange represents IFNRA, pink represents CD68, and blue represents the nucleus). <bold>(B)</bold> is the Panel 2. It shows the expression and distribution of IRF3, IRF5, and IRF7 in liver tissues of the deceased twins and control group respectively (green represents IRF7, yellow represents IRF5, orange represents IRF3, pink represents CD68 and blue represents the nucleus).</p>
</caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnes</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>P. A.</given-names>
</name>
<name>
<surname>Pitha</surname> <given-names>P. M.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes</article-title>. <source>J. Biol. Chem.</source> <volume>276</volume>, <fpage>23382</fpage>&#x2013;<lpage>23390</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M101216200</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnes</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>Richards</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Mancl</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hanash</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Beretta</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Pitha</surname> <given-names>P. M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection</article-title>. <source>J. Biol. Chem.</source> <volume>279</volume>, <fpage>45194</fpage>&#x2013;<lpage>45207</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M400726200</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brownell</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Polyak</surname> <given-names>S. J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer</article-title>. <source>Clin. Cancer Res.</source> <volume>19</volume>, <fpage>1347</fpage>&#x2013;<lpage>1352</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-12-0928</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bubba</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Martinelli</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Pellegrinelli</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Primache</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Tanzi</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Pariani</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>A 4-year study on epidemiologic and molecular characteristics of human parechoviruses and enteroviruses circulating in children younger than 5 years in northern Italy</article-title>. <source>Pediatr. Infect. Dis. J.</source> <volume>36</volume>, <fpage>13</fpage>&#x2013;<lpage>19</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/INF.0000000000001344</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>L. J.</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>X. Y.</given-names>
</name>
<name>
<surname>Niu</surname> <given-names>J. Q.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>CXC chemokine IP-10: a key actor in liver disease</article-title>? <source>Hepatol. Int.</source> <volume>7</volume>, <fpage>798</fpage>&#x2013;<lpage>804</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12072-013-9445-0</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>T. Y.</given-names>
</name>
<name>
<surname>Hsieh</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>K. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Clinical characteristics of echovirus 11 and coxsackievirus B5 infections in Taiwanese children requiring hospitalization</article-title>. <source>J. microbiology immunology infection</source> <volume>54</volume>, <fpage>581</fpage>&#x2013;<lpage>587</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jmii.2020.06.008</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chuang</surname> <given-names>Y. Y.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y. C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Enteroviral infection in neonates</article-title>. <source>J. microbiology immunology infection</source> <volume>52</volume>, <fpage>851</fpage>&#x2013;<lpage>857</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jmii.2019.08.018</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>W. X.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Kupffer cells promote T-cell hepatitis by producing CXCL10 and limiting liver sinusoidal endothelial cell permeability</article-title>. <source>Theranostics</source> <volume>10</volume>, <fpage>7163</fpage>&#x2013;<lpage>7177</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/thno.44960</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drummond</surname> <given-names>C. G.</given-names>
</name>
<name>
<surname>Bolock</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Luke</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Good</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Coyne</surname> <given-names>C. B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Enteroviruses infect human enteroids and induce antiviral signaling in a cell lineage-specific manner</article-title>. <source>Proc. Natl. Acad. Sci. United States America</source> <volume>114</volume>, <fpage>1672</fpage>&#x2013;<lpage>1677</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1617363114</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elkon</surname> <given-names>K. B.</given-names>
</name>
<name>
<surname>Briggs</surname> <given-names>T. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The (Orf)ull truth about IRF5 and type I interferons in SLE</article-title>. <source>Nat. Rev. Rheumatol.</source> <volume>16</volume>, <fpage>543</fpage>&#x2013;<lpage>544</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41584-020-0472-7</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garmaroudi</surname> <given-names>F. S.</given-names>
</name>
<name>
<surname>Marchant</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Hendry</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Coxsackievirus B3 replication and pathogenesis</article-title>. <source>Future Microbiol.</source> <volume>10</volume>, <fpage>629</fpage>&#x2013;<lpage>653</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2217/fmb.15.5</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grapin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mirand</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Pinquier</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Basset</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bendavid</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bisseux</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023</article-title>. <source>Euro surveillance</source> <volume>28</volume>, <elocation-id>2300253</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.2807/1560-7917.ES.2023.28.22.2300253</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hervas-Stubbs</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Riezu-Boj</surname> <given-names>J. I.</given-names>
</name>
<name>
<surname>Gonzalez</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Manche&#xf1;o</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Dubrot</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Azpilicueta</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Effects of IFN-&#x3b1; as a signal-3 cytokine on human na&#xef;ve and antigen-experienced CD8(+) T cells</article-title>. <source>Eur. J. Immunol.</source> <volume>40</volume>, <fpage>3389</fpage>&#x2013;<lpage>3402</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201040664</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Chiu</surname> <given-names>C. H.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Lien</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>S. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Investigation and successful control of an echovirus 11 outbreak in neonatal intensive care units</article-title>. <source>Pediatr. neonatology</source> <volume>61</volume>, <fpage>180</fpage>&#x2013;<lpage>187</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pedneo.2019.09.012</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>H. I.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Chiang</surname> <given-names>H. C.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>P. N.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Q. D.</given-names>
</name>
<name>
<surname>Shih</surname> <given-names>S. R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Exosomes facilitate transmission of enterovirus A71 from human intestinal epithelial cells</article-title>. <source>J. Infect. Dis.</source> <volume>222</volume>, <fpage>456</fpage>&#x2013;<lpage>469</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jiaa174</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jefferies</surname> <given-names>C. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Regulating IRFs in IFN driven disease</article-title>. <source>Front. Immunol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.00325</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>TBK1 and IRF3 are potential therapeutic targets in Enterovirus A71-associated diseases</article-title>. <source>PloS Negl. Trop. Dis.</source> <volume>17</volume>, <elocation-id>e0011001</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0011001</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Massilamany</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Gangaplara</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Reddy</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy</article-title>. <source>Int. J. Cardiol.</source> <volume>177</volume>, <fpage>330</fpage>&#x2013;<lpage>339</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijcard.2014.09.136</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morosky</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wells</surname> <given-names>A. I.</given-names>
</name>
<name>
<surname>Lemon</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Evans</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Schamus</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Bakkenist</surname> <given-names>C. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>The neonatal Fc receptor is a pan-echovirus receptor</article-title>. <source>Proc. Natl. Acad. Sci. United States America</source> <volume>116</volume>, <fpage>3758</fpage>&#x2013;<lpage>3763</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1817341116</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moshiri</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Craven</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Mixon</surname> <given-names>S. B.</given-names>
</name>
<name>
<surname>Amieva</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Kirkegaard</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Mechanosensitive extrusion of Enterovirus A71-infected cells from colonic organoids</article-title>. <source>Nat. Microbiol.</source> <volume>8</volume>, <fpage>629</fpage>&#x2013;<lpage>639</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-023-01339-5</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nie</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>The protective effect of interfering TLR9-IRF5 signaling pathway on the development of CVB3-induced myocarditis</article-title>. <source>Clin. Immunol.</source> <volume>207</volume>, <fpage>24</fpage>&#x2013;<lpage>35</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.clim.2019.07.002</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Daniel</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Mathan</surname> <given-names>V. I.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>An epidemic of acute diarrhoea in rural southern India associated with echovirus type 11 infection</article-title>. <source>J. hygiene</source> <volume>95</volume>, <fpage>483</fpage>&#x2013;<lpage>492</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/S0022172400062902</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paun</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Reinert</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Medin</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Balkhi</surname> <given-names>M. Y.</given-names>
</name>
<name>
<surname>Fitzgerald</surname> <given-names>K. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response</article-title>. <source>J. Biol. Chem.</source> <volume>283</volume>, <fpage>14295</fpage>&#x2013;<lpage>14308</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M800501200</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piralla</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Borghesi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Di Comite</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Giardina</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Ferrari</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Zanette</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Fulminant echovirus 11 hepatitis in male non-identical twins in northern Italy, April 2023</article-title>. <source>Euro surveillance</source> <volume>28</volume>, <elocation-id>2300289</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.2807/1560-7917.ES.2023.28.24.2300289</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasti</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Khanbabaei</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Teimoori</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>An update on enterovirus 71 infection and interferon type I response</article-title>. <source>Rev. Med. Virol.</source> <volume>29</volume>, <elocation-id>e2016</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/rmv.2016</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saxena</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>X. L.</given-names>
</name>
<name>
<surname>Blutt</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Crawford</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Sastri</surname> <given-names>N. P.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection</article-title>. <source>Proc. Natl. Acad. Sci. United States America</source> <volume>114</volume>, <fpage>E570</fpage>&#x2013;<lpage>E579</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1615422114</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname> <given-names>W. M.</given-names>
</name>
<name>
<surname>Chevillotte</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Rice</surname> <given-names>C. M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Interferon-stimulated genes: a complex web of host defenses</article-title>. <source>Annu. Rev. Immunol.</source> <volume>32</volume>, <fpage>513</fpage>&#x2013;<lpage>545</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120231</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vilcek</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>I. C.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Recent progress in the elucidation of interferon-gamma actions: molecular biology and biological functions</article-title>. <source>Int. Arch. Allergy Immunol.</source> <volume>104</volume>, <fpage>311</fpage>&#x2013;<lpage>316</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000236685</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>a). <article-title>Sustained induction of IP-10 by MRP8/14 via the IFN&#x3b2;-IRF7 axis in macrophages exaggerates lung injury in endotoxemic mice</article-title>. <source>Burns Trauma</source> <volume>11</volume>, <elocation-id>tkad006</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/burnst/tkad006</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>b). <article-title>Risk factors and early markers for echovirus type 11 associated haemorrhage-hepatitis syndrome in neonates, a retrospective cohort study</article-title>. <source>Front. Pediatr.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fped.2023.1063558</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wells</surname> <given-names>A. I.</given-names>
</name>
<name>
<surname>Grimes</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Coyne</surname> <given-names>C. B.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Enterovirus replication and dissemination are differentially controlled by type I and III interferons in the gastrointestinal tract</article-title>. <source>mBio</source> <volume>13</volume>, <elocation-id>e0044322</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mbio.00443-22</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wells</surname> <given-names>A. I.</given-names>
</name>
<name>
<surname>Grimes</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Branche</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Bakkenist</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>DePas</surname> <given-names>W. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in mice</article-title>. <source>PloS Pathog.</source> <volume>17</volume>, <elocation-id>e1009252</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1009252</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B</article-title>. <source>Front. Microbiol.</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2022.1052917</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Niu</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization</article-title>. <source>Cell Death Dis.</source> <volume>13</volume>, <fpage>411</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-022-04802-z</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>He</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Clinical characteristics of severe neonatal enterovirus infection: a systematic review</article-title>. <source>BMC Pediatr.</source> <volume>21</volume>, <fpage>127</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12887-021-02599-y</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>